<> Morepen Laboratories Share Price Today: Live Morepen Laboratories Share Price NSE/BSE | 5paisa
MOREPENLAB

Morepen Laboratories Share PriceMorepen Laboratories

₹28.75
0.2 (0.7%)
As on 30 January, 2023 | 09:53 BSE: 500288 NSE: MOREPENLAB

Morepen Laboratories Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Morepen Laboratories

Start SIP

Morepen Laboratories Share Price

  • Over 1 Month -21.35%
  • Over 3 Month 9.19%
  • Over 6 Month -22.5%
  • Over 1 Year -42.6%

Morepen Laboratories Key Statistics

P/E Ratio 26.6
PEG Ratio -0.5
Market Cap Cr 1,470
Price to Book Ratio 2.5
EPS 2
Dividend 0
Relative Strength Index 30.57
Money Flow Index 23.75
MACD Signal -0.44
Average True Range 1.63

Morepen Laboratories Investment Rating

  • Master Rating:
  • Morepen Laboratories has an operating revenue of Rs. 1,470.16 Cr. on a trailing 12-month basis. An annual revenue growth of 30% is outstanding, Pre-tax margin of 8% is okay, ROE of 17% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 52 which is a POOR score indicating inconsistency in earnings, a RS Rating of 18 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 118 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Morepen Laboratories Financials
IndicatorSep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 383274342
Operating Expenses Qtr Cr 356261323
Operating Profit Qtr Cr 271419
Depreciation Qtr Cr 445
Interest Qtr Cr 001
Tax Qtr Cr 632
Net Profit Qtr Cr 17714

Morepen Laboratories Technicals

EMA & SMA

Current Price
₹28.75
0.2 (0.7%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 32.25
  • 50 Day
  • 32.42
  • 100 Day
  • 32.66
  • 200 Day
  • 35.21
  • 20 Day
  • 33.12
  • 50 Day
  • 32.65
  • 100 Day
  • 30.85
  • 200 Day
  • 35.13

Morepen Laboratories Resistance and Support

PIVOT
₹28.7
Resistance
First Resistance 29.95
Second Resistance 31.35
Third Resistance 32.6
RSI 30.57
MFI 23.75
MACD Single Line -0.44
MACD -1.07
Support
First Resistance 27.3
Second Resistance 26.05
Third Resistance 24.65

Morepen Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 6,204,552 217,717,730 35.09
Week 5,271,059 160,451,044 30.44
1 Month 7,241,274 161,190,754 22.26
6 Month 5,186,326 144,905,951 27.94

Morepen Laboratories Result Highlights

Morepen Laboratories Synopsis

NSE-Medical-Diversified

Morepen Labs.Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1449.27 Cr. and Equity Capital is Rs. 95.56 Cr. for the Year ended 31/03/2022. Morepen Laboratories Ltd. is a Public Limited Listed company incorporated on 01/12/1984 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24231HP1984PLC006028 and registration number is 006028.
Market Cap 1,488
Sales 1,372
Shares in Float 31.69
No of funds 46
Yield
Book Value 2.28
U/D Vol ratio 1
LTDebt / Equity
Alpha -0.18
Beta 0.86

Morepen Laboratories

Owner NameDec-22Sep-22Jun-22May-22
Promoters 38.22%38.22%36.74%
Mutual Funds
Insurance Companies 1.07%1.07%1.1%
Foreign Portfolio Investors 0.89%1.15%0.95%
Financial Institutions/ Banks 2.33%0.38%2.98%
Individual Investors 44.03%43.63%40.91%
Others 13.46%15.55%17.32%

Morepen Laboratories Management

Name Designation
Mr. Sushil Suri Chairman & Managing Director
Mr. Sanjay Suri Whole Time Director
Mr. Manoj Joshi Independent Director
Mr. Bhupender Raj Wadhwa Independent Director
Mr. Sukhcharan Singh Independent Director
Mr. Praveen Kumar Dutt Independent Director
Mrs. Savita Independent Director

Morepen Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Morepen Laboratories Corporate Action

Date Purpose Remarks
2022-11-10 Quarterly Results
2022-07-29 Quarterly Results
2022-05-05 Audited Results
2022-02-08 Quarterly Results & Others
2021-11-11 Quarterly Results

Morepen Laboratories MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Morepen Laboratories FAQs

What is Share Price of Morepen Laboratories ?

Morepen Laboratories share price is ₹28 As on 30 January, 2023 | 09:39

What is the Market Cap of Morepen Laboratories ?

The Market Cap of Morepen Laboratories is ₹1469.6 Cr As on 30 January, 2023 | 09:39

What is the P/E ratio of Morepen Laboratories ?

The P/E ratio of Morepen Laboratories is 26.6 As on 30 January, 2023 | 09:39

What is the PB ratio of Morepen Laboratories ?

The PB ratio of Morepen Laboratories is 2.5 As on 30 January, 2023 | 09:39

Q2FY23